Diagnamed 

$0.037950
17
-$0.01-13.16% Thursday 19:00

Statistics

Day High
0.04
Day Low
0.04
52W High
0.14473
52W Low
0.024
Volume
10,000
Avg. Volume
21,354
Mkt Cap
4.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-1.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DGNMF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Idexx Laboratories
IDXX
Mkt Cap42.18B
IDEXX Laboratories is a direct competitor, offering diagnostic and testing solutions for animals, similar to Diagnamed's focus on healthcare diagnostics.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories competes in the diagnostics space with a broad range of medical devices, diagnostics, and nutritional products, overlapping with Diagnamed's market.
Danaher
DHR
Mkt Cap145.98B
Danaher Corporation operates in the diagnostics and research sector, providing similar diagnostic solutions and competing in the healthcare diagnostics market.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific offers a wide range of diagnostics and research products, directly competing with Diagnamed in the life sciences and healthcare sectors.
Bio-Rad Laboratories
BIO
Mkt Cap10.32B
Bio-Rad Laboratories provides clinical diagnostics and life science research products, making it a competitor in the diagnostics field.
Resmed
RMD
Mkt Cap32.94B
ResMed is involved in developing medical devices for respiratory disorders, competing indirectly by offering diagnostic and therapeutic devices in a related healthcare field.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation manufactures medical devices used in various medical specialties, including diagnostics, competing in the broader medical diagnostics and device market.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation, while primarily known for medical devices and equipment, also competes in the diagnostics space through its medical and surgical equipment that includes diagnostic products.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc offers medical devices and technology that compete in the broader healthcare market, including diagnostics and patient monitoring systems.

About

Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Andre Turmel
Country
Canada
ISIN
CA25245D1033
WKN
000A3D1VX

Listings

0 Comments

Share your thoughts

FAQ

What is Diagnamed stock price today?
The current price of DGNMF is $0.04 USD — it has decreased by -13.16% in the past 24 hours. Watch Diagnamed stock price performance more closely on the chart.
What is Diagnamed stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Diagnamed stocks are traded under the ticker DGNMF.
Is Diagnamed stock price growing?
DGNMF stock has fallen by -13.16% compared to the previous week, the month change is a -2.69% fall, over the last year Diagnamed has showed a -42.59% decrease.
What is Diagnamed market cap?
Today Diagnamed has the market capitalization of 4.99M
What is Diagnamed revenue for the last year?
Diagnamed revenue for the last year amounts to 0 USD.
What is Diagnamed net income for the last year?
DGNMF net income for the last year is -1.01M USD.
In which sector is Diagnamed located?
Diagnamed operates in the Health & Wellness sector.
When did Diagnamed complete a stock split?
Diagnamed has not had any recent stock splits.
Where is Diagnamed headquartered?
Diagnamed is headquartered in Toronto, Canada.